Back

The bleeding and cardiovascular risk according to NSAIDs selectivity in patients receiving antithrombotics and concomitant NSAIDs after myocardial infarction: a nationwide cohort study.

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2 Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Eun Jin Park

Korea University Guro Hospital, Seoul (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Doctor R. Rossini (Cuneo, IT)
Abstract Slides
Presentation thumbnail
Associate Professor B. Zheng (Beijing, CN)
Abstract
Presentation thumbnail
Doctor F. Loncaric (Zagreb, HR)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor L. Weidmann (Zurich, CH)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Coronary artery disease - Epidemiology and outcomes 2

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study
27 August 2023
thumbnail
Congress Presentation
Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3
1 September 2025
thumbnail
Webinar
Antithrombotic treatment for dual pathway inhibition in cardiovascular disease patients
19 July 2023
thumbnail
Congress Presentation
Post-discharge major bleeding, myocardial infarction and mortality risk after coronary artery bypass grafting: A nationwide cohort study from the SWEDEHEART registry
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources